| Nathan Scott Shurden, CRNA | |
|
823 Sw Mulvane, Suite 210, Topeka, KS 66606-1679 | |
| (785) 235-3451 | |
| Not Available |
| Full Name | Nathan Scott Shurden |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 823 Sw Mulvane, Topeka, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326331109 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 114793 (Kansas) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 1-113628 (Alabama) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Crestwood Medical Center | Huntsville, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physynergy Llc | 6204081292 | 65 |
News Archive
As many as one in 90 children are today being diagnosed with autism-and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates-environmental toxicity.
When people seek information on health-related symptoms, many turn to the internet, and Google in particular, as the first stop. Now, when consumers access Google's mobile search for information about certain symptoms, they will get facts on relevant related medical conditions up front on their smartphone or other mobile device.
Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics.
Difficulty or inability to write a coherent text message, even in patients who have no problem speaking, may become a "vital" tool in diagnosing a type of crippling stroke, according to new research at Henry Ford Hospital.
Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).
› Verified 4 days ago
| Entity Name | Anesthesia Services Of Decatur, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629034624 PECOS PAC ID: 4183618226 Enrollment ID: O20040412001701 |
News Archive
As many as one in 90 children are today being diagnosed with autism-and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates-environmental toxicity.
When people seek information on health-related symptoms, many turn to the internet, and Google in particular, as the first stop. Now, when consumers access Google's mobile search for information about certain symptoms, they will get facts on relevant related medical conditions up front on their smartphone or other mobile device.
Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics.
Difficulty or inability to write a coherent text message, even in patients who have no problem speaking, may become a "vital" tool in diagnosing a type of crippling stroke, according to new research at Henry Ford Hospital.
Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).
› Verified 4 days ago
| Entity Name | Eye Surgery Center Of North Alabama, Inc. |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1265657258 PECOS PAC ID: 1254424963 Enrollment ID: O20070911000188 |
News Archive
As many as one in 90 children are today being diagnosed with autism-and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates-environmental toxicity.
When people seek information on health-related symptoms, many turn to the internet, and Google in particular, as the first stop. Now, when consumers access Google's mobile search for information about certain symptoms, they will get facts on relevant related medical conditions up front on their smartphone or other mobile device.
Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics.
Difficulty or inability to write a coherent text message, even in patients who have no problem speaking, may become a "vital" tool in diagnosing a type of crippling stroke, according to new research at Henry Ford Hospital.
Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).
› Verified 4 days ago
| Entity Name | Physynergy Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134465560 PECOS PAC ID: 6204081292 Enrollment ID: O20130222000456 |
News Archive
As many as one in 90 children are today being diagnosed with autism-and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates-environmental toxicity.
When people seek information on health-related symptoms, many turn to the internet, and Google in particular, as the first stop. Now, when consumers access Google's mobile search for information about certain symptoms, they will get facts on relevant related medical conditions up front on their smartphone or other mobile device.
Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics.
Difficulty or inability to write a coherent text message, even in patients who have no problem speaking, may become a "vital" tool in diagnosing a type of crippling stroke, according to new research at Henry Ford Hospital.
Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).
› Verified 4 days ago
| Entity Name | Epix Anesthesia Of Alabama Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629427059 PECOS PAC ID: 8022300748 Enrollment ID: O20160715001459 |
News Archive
As many as one in 90 children are today being diagnosed with autism-and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates-environmental toxicity.
When people seek information on health-related symptoms, many turn to the internet, and Google in particular, as the first stop. Now, when consumers access Google's mobile search for information about certain symptoms, they will get facts on relevant related medical conditions up front on their smartphone or other mobile device.
Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics.
Difficulty or inability to write a coherent text message, even in patients who have no problem speaking, may become a "vital" tool in diagnosing a type of crippling stroke, according to new research at Henry Ford Hospital.
Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nathan Scott Shurden, CRNA 4100 W 24th Pl, Apt A9, Lawrence, KS 66047-2351 Ph: (785) 424-5712 | Nathan Scott Shurden, CRNA 823 Sw Mulvane, Suite 210, Topeka, KS 66606-1679 Ph: (785) 235-3451 |
News Archive
As many as one in 90 children are today being diagnosed with autism-and autism research continues to focus almost exclusively on genetics. In its January/February 2010 issue (posted now at: www.emagazine.com), E-The Environmental Magazine looks at another factor that may be driving up autism rates-environmental toxicity.
When people seek information on health-related symptoms, many turn to the internet, and Google in particular, as the first stop. Now, when consumers access Google's mobile search for information about certain symptoms, they will get facts on relevant related medical conditions up front on their smartphone or other mobile device.
Scientists have discovered a new pathway the dengue virus takes to suppress the human immune system. This new knowledge deepens our understanding of the virus and could contribute to the development of more effective therapeutics.
Difficulty or inability to write a coherent text message, even in patients who have no problem speaking, may become a "vital" tool in diagnosing a type of crippling stroke, according to new research at Henry Ford Hospital.
Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).
› Verified 4 days ago
Roger Vickery, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2200 Sw 6th Ave, Topeka, KS 66606 Phone: 785-354-8518 Fax: 785-354-1255 | |
Shannon Schwarz, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Sw 7th St, Topeka, KS 66606 Phone: 785-295-8111 | |
Michelle D Andrews, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 823 Sw Mulvane St, Suite 210, Topeka, KS 66606 Phone: 785-235-3451 Fax: 785-235-1435 | |
Lindsey E Dunn, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1500 Sw 10th Ave, Topeka, KS 66604 Phone: 785-354-6000 | |
Donald I Pekrul, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 823 Sw Mulvane St, Suite 210, Topeka, KS 66606 Phone: 785-235-3451 Fax: 785-235-1435 | |
Laci Lee Hansen, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 823 Sw Mulvane St, Suite 210, Topeka, KS 66606 Phone: 785-235-3451 | |
Brett Barkemeyer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1700 Sw 7th St, Topeka, KS 66606 Phone: 952-442-9770 |